Hercules Capital Inc.

HTGC
Financial Analysis · Updated May 29, 2026 · Coverage 2026-Q2
Latest Q Revenue
$137.4M
Q4 2025 · +5.7% YoY
TTM ROIC
16.3%
FY2025 · NII Yield on Average NAV (NII ÷ average NAV); BDC-adapted metric as standard ROIC does not apply to BDCs · WACC ~8.5% · Moat spread +7.8pp
Margin Profile
Operating 64.1%
FY2025
Diluted Shares
183M
FY2025

Business Overview


source: coverage-next-full ticker: HTGC step: 01 title: Business Model Overview created: 2026-05-28

Step 01 — Business Model: Hercules Capital, Inc. (HTGC)

1. Business Description

Hercules Capital, Inc. [S1] is the largest and leading non-bank provider of venture growth debt to technology and life sciences companies in the United States. Founded in 2003 and publicly listed in December 2005 on NYSE, Hercules operates as an internally managed Business Development Company (BDC) regulated under the Investment Company Act of 1940. Since inception, the company has committed over $25 billion to more than 700 portfolio companies [S2].

The company's primary business is making senior secured, floating-rate venture growth loans — typically first-lien — to high-growth, venture capital-backed companies that are pre-profitability or in rapid scaling phases. These borrowers cannot access traditional bank credit (no EBITDA) but have strong VC sponsor backing and often a clear path to exit (IPO, acquisition, or next equity round).

2. Value Chain Layer Map

[VC Ecosystem] → [Portfolio Companies] → [Hercules Capital] → [Capital Markets / Investors]
    |                    |                      |
Sequoia, A16z,     ~$20-40M                Originates,          NYSE: HTGC
Kleiner, NEA,      senior secured          underwrites,         Dividend income
Andreessen...      floating-rate           monitors,            to shareholders
                   loans + warrants        exits

Hercules' position: Capital intermediary between institutional capital markets and VC-backed borrowers. Unlike banks (which require EBITDA), HTGC lends against venture capital sponsorship quality, technology merit, and liquidity runway.

3. Revenue Model

HTGC generates revenue through three streams [S3]:

Revenue Stream FY2025 Mix Description
Interest Income ~85% Floating rate (SOFR + spread); 12.5-12.9% effective yield
Fee Income ~5% Origination, commitment, prepayment fees
PIK Income ~10% Payment-in-kind (accrued, not cash); 10.4% of Q4'25 revenue
Equity/Warrant Modest Gains from warrants; lumpier, smaller as % of total

Total Investment Income FY2025: $532.5M [S4] Net Investment Income FY2025: $341.7M [S4]

4. Internal Management Advantage

Unlike ~80% of BDCs which are externally managed, HTGC is internally managed [S1]. This eliminates:

  • External management fee (typically 1.5-2.0% of assets)
  • Incentive fee conflicts (external managers may prioritize fee income over NII quality)

Cost benefit: At HTGC's $4.6B asset base, a 1.5% management fee would equate to ~$69M/year — returned directly to shareholders as NII instead. This structural advantage directly lifts NII/share by an estimated $0.35-0.40/share vs. external peers at similar scale.

5. Origination Platform

Platform Scale (FY2025): ~$5.7B total AUM [S2], including:

  • HTGC balance sheet (~$4.6B assets)
  • Managed/advised funds (institutional capital co-investing)

Origination approach: Hercules originates through deep integration with top-tier VC firms. When a portfolio company of Sequoia, Andreessen Horowitz, NEA, or Kleiner Perkins seeks growth debt, Hercules is typically the first call. This relationship moat creates a proprietary deal flow that smaller or generalist lenders cannot easily replicate.

Typical loan structure:

  • Loan size: $20-40M (range: $5M–$150M+)
  • Term: 24-48 months
  • Rate: SOFR + 6-9% spread (effective ~12-14%)
  • Security: First lien on all assets
  • Warrants: Equity kicker (declining % of total return over time)
  • Amortization: Interest-only period + balloon principal

6. Portfolio Composition (FY2025)

  • Portfolio Fair Value: $4.47B [S1]
  • Portfolio companies: ~116-120 active (estimate from scale data)
  • Sector split (approximate): Technology ~65-70%, Life Sciences ~25-30%, Other ~5%
  • Technology sub-sectors: Software, SaaS, fintech, semiconductor, AI/ML
  • Life Sciences sub-sectors: Drug development, medical devices, health IT
  • % First Lien: ~90% [S2]
  • % Floating Rate: 97.8% [S2]
  • Effective GAAP Yield: 12.9% | Core Yield: 12.5% [S2]

7. Business Model Risks

  1. Credit cycle exposure: Venture-stage borrowers have no EBITDA safety cushion — in a downturn, non-accruals can spike rapidly
  2. Floating rate double-edge: Rate increases drive NII up, but rate cuts (2024-2026) compress NII from the same mechanism
  3. Equity kicker erosion: Warrant income was historically 5-10% of total return; IPO market weakness reduces this component
  4. PIK income quality: PIK accruals are economically equivalent to extending credit — if uncollected, they become additional loan losses
  5. ATM dilution dependency: Growth requires continuous equity issuance; if stock drops below NAV, ATM issuance becomes NAV-destructive

8. Competitive Moat Summary

Moat Factor Rating Evidence
VC ecosystem relationships Strong 20+ years, 700+ companies, $25B committed
Internal management Structural ~$0.35-0.40/share NII advantage vs. peers
Scale as origination advantage Moderate Can serve larger loans; $5.7B AUM platform
Brand/reputation Moderate "2025 Americas BDC Manager of the Year" (Private Debt Investor) [S3]
Switching costs Weak Borrowers can refinance; sponsor relationships are real but not contractual

Source Index

  • [S1] SEC EDGAR, company website (htgc.com/about/)
  • [S2] HTGC Q4 FY2025 press release / earnings prepared remarks (investor.htgc.com, Motley Fool)
  • [S3] Private Debt Investor award (investor.htgc.com press release, 2026)
  • [S4] SEC XBRL company facts, HTGC FY2025 10-K

Transcript analysis not performed — coverage-next-full path (filings and press releases only).

Financial Snapshot


source: coverage-next-full ticker: HTGC step: 04 title: Financial Snapshot & Adversarial Sweep created: 2026-05-29

Step 04 — Financial Snapshot & Adversarial Sweep: Hercules Capital, Inc. (HTGC)

Note: Transcript analysis not performed — this is the filings-and-consensus path.

1. BDC Financial Statement Framework

HTGC reports under Investment Company accounting (ASC 946), not standard GAAP. Key statement differences:

  • Income statement: "Total Investment Income" replaces "Revenue"; "Net Investment Income (NII)" replaces "Operating Income"
  • Balance sheet: "Net Assets" = NAV; portfolio investments carried at fair value (not cost)
  • No depreciation/amortization: BDC does not own long-lived assets
  • Realized/unrealized gains: Separate from NII; included in total "Net Increase in Net Assets from Operations"

2. Three-Year Financial Snapshot (BDC Metrics)

Annual NII & NAV Summary
Metric FY2025 FY2024 FY2023 FY2022
Total Investment Income (TII) $532.5M $493.6M $426.5M ~$295M
Net Investment Income (NII) $341.7M $325.8M $304.0M ~$200M
NII per Share ~$1.91 ~$2.01 ~$2.13 ~$1.58
NAV per Share (year-end) $12.13 $11.66 $12.45 $11.06
Total Dividends/Share $1.88 $1.76 $1.68 $1.52
NII Coverage of Dividends ~102% ~114% ~127% ~104%
Net Assets (NAV total) $2,216M $1,990M $1,803M $1,401M
Total Assets $4,584M $3,832M $3,417M $3,029M
Total Debt $2,286M $1,769M $1,555M $1,574M

Sources: [S2] StockAnalysis, [S4] Q4 2025 press release, [S8] Q4 2024 press release

Quarterly NII & NAV (Most Recent 8 Quarters)
Quarter NII/Share NAV/Share Div/Share Coverage
Q4 2025 $0.48 $12.13 $0.47 102%
Q3 2025 $0.49 $12.05 $0.47 104%
Q2 2025 $0.50 $11.84 $0.47 106%
Q1 2025 $0.45 $11.55 $0.47 96%
Q4 2024 $0.48 $11.66 $0.44 109%
Q3 2024 ~$0.47 ~$11.40 $0.44 ~107%
Q2 2024 ~$0.46 ~$11.15 $0.44 ~105%
Q1 2024 ~$0.55 ~$11.65 $0.44 ~125%

Sources: [S4][S5][S6][S7][S8]

NII Coverage Trend: Declining from peak (2022-2023 rate-surge beneficiary) as rates stabilized. Q4 2025 base distribution covered at 120% ($0.48 NII vs. $0.40 base cash distribution). Supplemental distributions drew from $149.9M undistributed earnings spillover [S4].

Return Metrics (BDC-Adapted)
Metric FY2025 FY2024 FY2023
NII Yield on Beginning NAV ~17.2% ~18.1% ~21.7%
ROE (net income / avg equity) ~16.0% ~17.0% ~21.0%
Effective Portfolio Yield (core) ~12.7% ~12.9% ~13.5%
Leverage (Debt/Equity) 1.03x 0.89x 0.86x
Net Regulatory Leverage 86.0% ~80% ~75%

Note: ROE includes unrealized gains/losses; NII yield is a cleaner operating metric for BDCs [Judgment]

3. Accounting Quality Assessment

Fair Value Methodology (Level 3 Concerns)

HTGC marks substantially all portfolio investments at Level 3 fair value (unobservable inputs), as is standard for BDC private credit portfolios [S3]. Key valuation inputs include:

  • Yield analysis (market credit spreads vs. portfolio coupon)
  • Market comparables for equity/warrant positions
  • Internal credit ratings (1–5 scale, with 1 = highest quality)

Board Valuation Committee: As of December 31, 2024, weighted average internal rating was 2.20 (improved from prior periods) [S13]. HTGC uses external third-party valuation services for Level 3 assets, a standard BDC practice.

PIK Income Recognition: Payment-in-kind interest accrues as income before cash collection. As of 2025, Hunterbrook Research reported PIK receivables of ~$109.1M outstanding with cash collected of ~$4.9M in 2025 — implying elevated PIK accrual-to-cash gap [S10]. This is a monitoring risk, not confirmed accounting fraud.

Adjustment Notes
  • BDC NII excludes unrealized appreciation/depreciation (proper treatment)
  • Management expense ratio: As an internally managed BDC, HTGC's operating expenses include employee comp, overhead, G&A — no external management fee or incentive fee paid to a third party [S3, JUDGMENT]
  • Effective cost of management: Approximately 3.5–4.5% of average assets (estimated from OpEx/total assets), vs. 1.5–2.0% base + 20% incentive for externally managed BDCs [JUDGMENT]

4. Adversarial Research Sweep

Short Reports & Negative Research

Hunterbrook Research — "The Myth of Hercules Capital" (2025) [S10]

Hunterbrook published a notable short thesis with the following claims:

  1. PIK income inflated: PIK interest income doubled to $55.9M in 2025; cash collected collapsed 73% to $4.9M; outstanding PIK receivables nearly tripled to $109.1M.
  2. Thin dividend coverage: Total 2025 distributions of $1.88/share covered by $1.91 NII/share — 3-cent margin; on cash NII basis, base distribution coverage at ~105.7%.
  3. Portfolio turnover misrepresentation: Management's 18–24 month turnover narrative contradicted by 16-quarter analysis showing only ~36% of new fundings to new borrowers.
  4. Valuation methodology concerns: Former finance team member cited "four people" handling valuations with minimal cross-checks.
  5. Unique cumulative loss metric: HTGC's 3-basis-point cumulative loss rate nets warrant gains against loan losses — methodology not identified in other major BDCs.
  6. Premium sustainability: ~25% premium to NAV is the highest among software-exposed BDCs; similar dynamic to TriplePoint Venture Growth before its dividend cut.

Company Response / Counterarguments:

  • HTGC's non-accrual rate as of Q4 2025 was 0.1% at fair value — record low [S13] — suggesting credit quality improvement, not deterioration.
  • PIK income is disclosed clearly; not unique to HTGC; accrues before cash collection by design.
  • Internally managed structure eliminates external fee drag; operating expenses are fully transparent [S4].
  • FY2025 TII grew 7.9% YoY to $532.5M; NII grew 4.9% to $341.7M — operational momentum continues [S4].

Assessment: Hunterbrook raises legitimate monitoring flags (PIK income quality, thin supplemental dividend coverage) but the fraud/misrepresentation allegations have not been corroborated by external auditors or regulatory action. The short case is more a valuation/risk argument than an accounting fraud thesis. [JUDGMENT]

Legal/Regulatory Matters

No material pending litigation or SEC investigation identified as of 2025 [FACT from absence of disclosure in press releases].

Credit Rating
  • KBRA (KROLL) maintains investment-grade ratings on HTGC unsecured notes, affirmed as of 2025 [S14 via web search].

5. Financial Quality Score

Dimension Score Notes
Revenue recognition B+ Standard BDC accrual; PIK monitoring warranted
Fair value rigor B Level 3 reliance is industry-standard; external valuers used
Dividend sustainability B Base covered at 120%; supplemental draws from spillover
Leverage conservatism A- Net regulatory leverage 86%; well below 150% BDC cap
Management incentive alignment A Internally managed; CEO owns meaningful equity
Disclosure quality B+ Detailed quarterly releases; NII, NAV, non-accrual disclosed

Overall Financial Quality: B+ — Above-average for the BDC sector. PIK concentration and thin supplemental dividend margin are the primary watchpoints.

6. Source Index

ID Source
S2 StockAnalysis.com HTGC financials (annual + quarterly)
S3 Investment Company Act of 1940; BDC regulatory framework
S4 Hercules Capital 8-K Q4/FY2025 earnings release (investor.htgc.com)
S5 SEC 8-K Q3 2025: htgcq32025release.htm
S6 SEC 8-K Q2 2025: htgcq22025release.htm
S7 SEC 8-K Q1 2025: htgcq12025release.htm
S8 SEC 8-K Q4 2024: htgcq42024release.htm
S10 Hunterbrook Research: "The Myth of Hercules Capital" (hntrbrk.com)
S13 Fintool Q4 2025 earnings analysis
S14 KBRA rating affirmation (kbra.com, web search)

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $HTGC.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/HTGC/fundamental$1.00 · Bearer token required
Markdown: /stocks/htgc/financials/md · → thesis · → memo